Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q1 2023 Earnings Call Transcript
Operator: Good day, everyone, and welcome to the Syndax First Quarter 2023 Earnings Conference Call. Today's call is being recorded.
Stay updated with breaking news from Dara Azar. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Good day, everyone, and welcome to the Syndax First Quarter 2023 Earnings Conference Call. Today's call is being recorded.
MassMEDIC Announces IGNITE 2021 Cohort Share Article MassMEDIC IGNITE, a virtual accelerator focused on identifying and nurturing the medtech leaders of the future, announced the 2021 Cohort, 12 start-ups selected from a record number of applicants. IGNITE, virtual accelerator for medtech founders and entrepreneurs "It’s already a banner year for IGNITE—with a record number of applicants, double the number of corporate sponsors, significant cash and services prizes, and the most diverse and inclusive cohort to date,” said Rachel Robinson, VP MassMEDIC. BO...